AsiaTIDES: Oligonucleotide and Peptide Therapeutics
About
Find R&D Innovations, Technologies and Partners to Advance Oligonucleotides and Peptides from Discovery through Manufacturing and Commercialization.
Day One
- Optional Workshop: Accelerating Oligonucleotides to IND and Beyond
- Optional Workshop: An Introduction to Peptide Therapeutic Development: Strategies for Moving to the Clinic, CMC and Beyond
- Plenary Keynote Presentations from Alnylam Pharmaceuticals, Novo Nordisk A/S, Ionis Pharmaceuticals, The University of Tokyo, Agilent Technologies
- Networking Dinner in Tokyo
Day Two
- Featured mRNA Therapeutics Session with speakers from Moderna Therapeutics, BioNTech AG, and CureVac AG
- Oligonucleotide Track: Optimizing Properties of Oligonucleotides/Oligonucleotide CMC Strategies
- Peptide Track: Peptide Discovery and Peptide Drug Targets/Peptide Synthesis/Optimizing Peptide Properties
- Evening Cocktail Networking Reception
Day Three
- NEW Regulatory Session from Fountain Medical Development, Regulatory Consulting, PPD, and Biologics Consulting Group
- Oligonucleotide Track: Delivery Strategies/Preclinical and Clinical Case Studies
- Peptide Track: Peptide CMC Strategies/Preclinical and Clinical Case Studies